Cargando…

Prognosis of “pre-heart failure” clinical phenotypes

BACKGROUND: Heart failure (HF) is a clinical syndrome where diagnostic certainty varies. The prognosis of individuals with some clinical features of HF, but without the fully overt syndrome, is unclear. Therefore, we sought to evaluate their natural history. METHODS AND RESULTS: Between 1990 and 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Velagaleti, Raghava S., Short, Meghan I., Larson, Martin G., Vasan, Ramachandran S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147998/
https://www.ncbi.nlm.nih.gov/pubmed/32275698
http://dx.doi.org/10.1371/journal.pone.0231254
_version_ 1783520507923005440
author Velagaleti, Raghava S.
Short, Meghan I.
Larson, Martin G.
Vasan, Ramachandran S.
author_facet Velagaleti, Raghava S.
Short, Meghan I.
Larson, Martin G.
Vasan, Ramachandran S.
author_sort Velagaleti, Raghava S.
collection PubMed
description BACKGROUND: Heart failure (HF) is a clinical syndrome where diagnostic certainty varies. The prognosis of individuals with some clinical features of HF, but without the fully overt syndrome, is unclear. Therefore, we sought to evaluate their natural history. METHODS AND RESULTS: Between 1990 and 2009, all suspected HF cases in the Framingham Heart Study were adjudicated into 3 groups reflecting varying diagnostic certainty: definite (meeting HF diagnostic criteria; n = 479), possible (meeting HF criteria but with an alternative explanation for findings; n = 135), and probable (insufficient criteria for definite HF; n = 121) HF. Age-and-sex-matched individuals (n = 1112) without HF or cardiovascular disease (CVD) were controls. Using multivariable-adjusted Cox regression, we compared the possible/probable HF groups with controls regarding risk of incident definite HF, coronary heart disease (CHD), other CVD or death; and with definite HF regarding risk of latter three outcomes. During follow-up (mean 8.6 years), ~90% of individuals with possible, probable and definite HF experienced CVD events or died. Compared with controls, those with possible or probable HF experienced higher hazards for definite HF, CHD, other CVD and death (hazards ratios [HR] 1.35–9.31; p<0.05). The possible/probable groups did not differ from the definite HF group for risk of any outcome. Compared with the possible HF group, the probable HF group had a higher propensity for definite HF (HR 1.64, with a higher proportion of ischemic HF) but lower risk of death (HR 0.69). CONCLUSIONS: Individuals meeting partial criteria for HF are at a substantial risk for progression to HF, CVD, and mortality.
format Online
Article
Text
id pubmed-7147998
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71479982020-04-14 Prognosis of “pre-heart failure” clinical phenotypes Velagaleti, Raghava S. Short, Meghan I. Larson, Martin G. Vasan, Ramachandran S. PLoS One Research Article BACKGROUND: Heart failure (HF) is a clinical syndrome where diagnostic certainty varies. The prognosis of individuals with some clinical features of HF, but without the fully overt syndrome, is unclear. Therefore, we sought to evaluate their natural history. METHODS AND RESULTS: Between 1990 and 2009, all suspected HF cases in the Framingham Heart Study were adjudicated into 3 groups reflecting varying diagnostic certainty: definite (meeting HF diagnostic criteria; n = 479), possible (meeting HF criteria but with an alternative explanation for findings; n = 135), and probable (insufficient criteria for definite HF; n = 121) HF. Age-and-sex-matched individuals (n = 1112) without HF or cardiovascular disease (CVD) were controls. Using multivariable-adjusted Cox regression, we compared the possible/probable HF groups with controls regarding risk of incident definite HF, coronary heart disease (CHD), other CVD or death; and with definite HF regarding risk of latter three outcomes. During follow-up (mean 8.6 years), ~90% of individuals with possible, probable and definite HF experienced CVD events or died. Compared with controls, those with possible or probable HF experienced higher hazards for definite HF, CHD, other CVD and death (hazards ratios [HR] 1.35–9.31; p<0.05). The possible/probable groups did not differ from the definite HF group for risk of any outcome. Compared with the possible HF group, the probable HF group had a higher propensity for definite HF (HR 1.64, with a higher proportion of ischemic HF) but lower risk of death (HR 0.69). CONCLUSIONS: Individuals meeting partial criteria for HF are at a substantial risk for progression to HF, CVD, and mortality. Public Library of Science 2020-04-10 /pmc/articles/PMC7147998/ /pubmed/32275698 http://dx.doi.org/10.1371/journal.pone.0231254 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Velagaleti, Raghava S.
Short, Meghan I.
Larson, Martin G.
Vasan, Ramachandran S.
Prognosis of “pre-heart failure” clinical phenotypes
title Prognosis of “pre-heart failure” clinical phenotypes
title_full Prognosis of “pre-heart failure” clinical phenotypes
title_fullStr Prognosis of “pre-heart failure” clinical phenotypes
title_full_unstemmed Prognosis of “pre-heart failure” clinical phenotypes
title_short Prognosis of “pre-heart failure” clinical phenotypes
title_sort prognosis of “pre-heart failure” clinical phenotypes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147998/
https://www.ncbi.nlm.nih.gov/pubmed/32275698
http://dx.doi.org/10.1371/journal.pone.0231254
work_keys_str_mv AT velagaletiraghavas prognosisofpreheartfailureclinicalphenotypes
AT shortmeghani prognosisofpreheartfailureclinicalphenotypes
AT larsonmarting prognosisofpreheartfailureclinicalphenotypes
AT vasanramachandrans prognosisofpreheartfailureclinicalphenotypes